Alstonia scholaris, commonly known as devil's tree is an important medicinal plant in the various folk and traditional systems of medicine in Asia, Australia, and Africa. The decoction, mostly prepared from the bark, is used to treat a variety of diseases of which the most important is malaria. Furthermore, ethnomedicinal practices also suggest it to be of use in treating cancer, and preclinical studies performed with cultured neoplastic cells and tumor-bearing animals having validated these observations. Additionally, the phytochemicals like echitamine, alstonine, pleiocarpamine, O-methylmacralstonine, macralstonine, and lupeol are also reported to possess antineoplastic effects. In addition to the cytotoxic effects, A scholaris is also observed to possess radiomodulatory, chemomodulatory, and chemopreventive effects and free-radical scavenging, antioxidant, anti-inflammatory, antimutagenic, and immunomodulatory activities, all of which are properties efficacious in the treatment and prevention of cancer. The current review for the first time summarizes the results related to these properties. An attempt is also made to address the lacunae in these published studies and emphasize aspects that need further investigations for it to be of use in clinics in the future.
Introduction
Complementary therapies based on herbal medicines are the world's most ancient form of medicine and recent reports suggest that such therapies still enjoy immense popularity, especially in developing countries where the majority of the population does not have easy access to modern medicine. 1 The traditional Indian system of medicine, Ayurveda, which means the science of life, is one of the world's oldest systems of medicines. Ayurveda predominantly uses plant-based formulations developed through the experimentation and experiences of physicians for centuries. 2 Some of the Indian plants have been investigated for their use in cancer and Alstonia scholaris is one of them. 3 A scholaris (L) R Br, belonging to the family Apocynaceae, is an important medicinal plant in the treatment of malaria in the Ayurveda and various folk systems of medicines. This plant is a native of India, Sri Lanka, Pakistan, Nepal, Thailand, Burma, Malaysia, South-East Asia, Africa, Northern Australia, Solomon Islands, and Southern China and grows to up to 100 m in height. 3,4(pp337-346) ,5(pp1308-1315)-9(pp205-207) It is a beautiful foliage tree with a large canopy, and because of this, it has become a popular ornamental tree in the landscapes and gardens in the warm and temperate regions of Florida, Texas, and California in the United States. 3 Historically, the plant was scientifically named by Linnaeus as Echites scholaris. However, to commemorate the great botanist Professor C. Alston, the generic name was changed to Alstonia, whereas the species name scholaris was retained to signify its use in schools in South East Asia, where the wood is traditionally used to make blackboards and wooden slates. The other synonyms of the plant include Tabernaemontana alternifolia Burm, Echites pala Buch-Ham ex Spreng, and Pala scholaris (L.) Roberty. 3 ,4(pp337-346),5(pp1308-1315)-9(pp205-207) In Sanskrit the plant is referred to as phalagaruda, sapthaparna, and saptaparni (sapta means 7 and parna or parni means leaves) because the leaves are found in whorls of 7 ( Figure 1 ). 3,4(pp337-346) ,5(pp1308-1315)- 9(pp205-207) The plant is commonly known in English as black board, milk wood, milky pine, white cheese wood, and devil's tree; chattin in Bengali; shaitan ped, Saittan ka jat in Hindi; chhataun, chhatiwan in Nepali; pala in Tamil; hale in Kannada; pulai, pule, and rite in Indonesian; pule in Javanese; tinpet in Lao; pulai and pulai linlin in Malay; sattaban, teenpet, and teenpethasaban in Thai; and caay mof cua and caay suwxa in Vietnamese. 3,4(pp337-346) ,5(pp1308-1315)- 9(pp205-207) Medicinally, the bark is the most valuable plant part and is used in various folk and traditional medicines. The infusion prepared from the bark is a bitter tonic, alterative, febrifuge, astringent, acrid, thermogenic, digestive, laxative, anthelmintic, antipyretic, depurative, galactogogue, stomachic, and cardiotonic. It is also of use in treating malarial fever, abdominal disorders, diarrhea, dysentery, dyspepsia, leprosy, skin diseases, pruritus, asthma, bronchitis, cardiopathy, helminthiasis, agalactia, and debility. 3,4(pp337-346),5(pp1308-1315)-9(pp205-207) Systemic consumption of the decoction is believed to improve digestion, prevent indigestion and dysentery, rectify liver disorders, decrease fever and asthma, and lessen chronic cough. It is also an effective blood purifier and affords cardioprotective effects. The bark paste is topically applied to heal chronic ulcers of the skin, and its regular consumption is recommended to decrease postdelivery weakness and increase lactation in mothers. 3,4(pp337-346),5(pp1308-1315)- 9(pp205-207) In Ayurveda, the bark is an integral part of many polyherbal formulations, the most important being the saptaparnaghana vati, saptachchhadadi kvatha, saptachchhadadi taila, saptaparnasatvadi vati, and mahatikta ghrita. 4(pp337-346),5(pp1308-1315),10 A scholaris is also a component of the proprietary polyherbal preparation Ayush-64 marketed in India to treat malaria. 8, 11 
Phytochemicals in A scholaris
Phytochemically, A scholaris is one of the most wellinvestigated plants, and nearly 400 compounds have been isolated and characterized. 12 The Alstonia species are rich in alkaloids, steroids, triterpenoids, and flavonoids. 3,5(pp1308-1315),7-9(pp205-207),12-14 Some of the most important alkaloids reported to be present are alstonidine, alstonine ( Figure 2 ), alstovenine, chlorogenic acid, chlorogenine, ditain, ditaine, ditamine, echicaoutchin, echicerin, echiretin, echitamine ( Figure 2 ), echitein, echitenin, echitin, porphyrine, porphyrosine, reserpine, venenatine, villalstonine pleiocarpamine, O-methylmacralstonine, macralstonine, O-acetylmacralstonine, villalstonine, macrocarpamine, corialstonine. corialstonidine, nareline, scholaricine, metylburnamine, and vallesamine. 3,8,9(pp205-207) , 12, 14 The triterpenoids lupeol linoleate, lupeol palmitate, and α-amyrin linoleate are present in the stem bark. 5(pp1308-1315),7-9 (pp205-207), [12] [13] [14] The seeds contain hallucinogenic indole alkaloids, which are alstovenine, venenatine, chlorogenine, reserpine, ditamine, echitamine, and chlorogenic acid. 14 According to a recent report, the leaves contain the following flavonoids: 13 The presence of these pharmacologically potent compounds is supposed to be responsible for the various pharmacological activities. 3,5(pp1308-1315),7-9(pp205-207)
The Cancer Preventive and Therapeutic Properties of Sapthaparna
Cancer is globally the second leading cause of death, and recent estimates suggest that in the year 2004, it accounted for 7.4 million deaths, which is approximately 13% of all the deaths. 15 Furthermore, projections are that the number of deaths caused by cancer will continue to rise, and with an estimated 12 million deaths in 2030, it will be the leading cause of death globally. 15 In clinics, depending on the stage of the cancer and the general health of the patient, the treatment strategies may include surgery, radiotherapy, and systemic treatments like hormonal ablation and chemotherapy. 16 In spite of the availability of large number of remedies, a definitive cure of cancer still remains elusive. The available anticancer drugs, including the ones derived from plants, have the potential to cause severe systemic toxicity. 17 Additionally, the treatment of cancer is very expensive and drains off a large part of the finances of a family, which for a poor patient is unaffordable. Therefore, there is a need to search for remedies that are economically affordable and do not have the severe side effects of modern drug formulations. Recently, the use of some herbs has attracted a great deal of attention as alternative cancer therapy owing to their lower toxicity and higher cost-effectiveness. 1
A scholaris in Treating Cancer
Since primeval times, herbal healers in India, the Admiralty Islands, and Thailand have been using the decoction of A scholaris to treat cancer, 4(pp337-346), 8, 18 and experimental studies performed following the modern system's pharmacological study guidelines have substantiated these ethnomedicinal observations. [19] [20] [21] The alcoholic extract of the bark has been reported to possess anticancer activity in HS1 human sarcoma in the embryonated egg. 9(pp205-207) Further studies by Keawpradub et al 22 have also shown that the methanolic extracts of the root bark of A macrophylla, A glaucescens, and A scholaris possess cytotoxic activity against human lung cancer cell lines, MOR-P (adenocarcinoma), and COR-L23 (largecell carcinoma). These results confirm that A scholaris as well as its sister species possess antineoplastic effects. 22 The bioactivities of plants are known to vary with the season, and to understand this, a study was undertaken to determine the variation in the antineoplastic activity of hydroalcoholic extract of A scholaris bark from the same tree using the cultured human cervical neoplastic cells, HeLa, in vitro. 20 The study showed that the degree of cell kill was dependent on the season when the plant bark was harvested. 20 The cytotoxic effects of the extract were highest in summer (IC50 of 30 µg/mL) followed by winter (IC50 of 45 µg/mL) and monsoon (IC50 of 55 µg/mL), respectively. 20 Fractionation-guided antineoplastic assay was also performed by fractionating the hydroalcoholic extract with solvents of different polarity (chloroform, petroleum ether, diethyl ether, ethyl acetate, n-butanol, aqueous) and then investigating them for their cytotoxic effects in HeLa cells. Echitamine, the principal alkaloid of A scholaris and a known anticancer agent was used as a positive control. 20 The study showed that the cytotoxicity declined in the order of extract residue fraction (IC50 = 8 µg/mL) > whole extract (IC50 = 30 µg/mL) > chloroform fraction (IC50 = 35 µg/ mL) > echitamine (IC50 = 47 µg/mL) > ethyl acetate fraction (IC50 = 73 µg/mL) > diethyl ether fraction (IC50 = 76 µg/ mL) > petroleum ether fraction (IC50 = 78 µg/mL) > n-butanol fraction (IC50 = 96 µg/mL) > aqueous fraction (IC50 = 96 µg/mL). 20 Preliminary phytochemical studies showed that the extract residue fraction, whole extract, and chloroform fractions were rich in alkaloids, and because some of the alkaloids have antitumoral properties, this might have been responsible for the observed antineoplastic effects of these extracts. 20 The extract residue fraction was also observed to possess potent antitumoral effects in tumor-bearing mice, suggesting that the in vitro observations extended to in vivo studies. 21 With regard to isolated phytochemicals, comparative studies by Keawpradub et al, 22 have shown that the compound villalstonine was more cytotoxic than pleiocarpamine, O-methylmacralstonine, and macralstonine. 22 Additionally, echitamine, the major constituent of A scholaris, is reported to possess cytotoxic effects in HeLa, HepG2, HL60, KB, MCF-7 cells, 23 Vero cells, fibrosarcoma, 24, 25 and Ehrlich ascites carcinoma 26 in vitro, and was also effective in controlling the growth of fibrosarcoma in rats, 24 sarcoma-180, [27] [28] [29] and Ehrlich ascites carcinoma in mice. 23 In vivo studies with methylcholanthrene-induced fibrosarcoma rats have shown that the anticancer activity of echitamine extended to an in vivo system and that a significant regression in tumor growth was seen. Echitamine normalized the altered activities of plasma and liver transaminases, liver γ-glutamyl transpeptidase, and lipid peroxidation. It also regularized the liver glutathione levels and the activities of glutathione peroxidase, superoxide dismutase, and catalase to near normal. 24, 25 Studies with S-180 cells have shown that echitamine rectified the impaired drug detoxifying system and affected cellular and mitochondrial respiration, which cumulatively may have reduced the cellular energy pool and caused loss of viability. [27] [28] [29] Alstonine, another indole alkaloid present in A scholaris, is reported to possess antineoplastic effects in transplantable YC8 lymphoma ascites-bearing mice (BALB/C mice) and in Ehrlich ascites carcinoma-bearing Swiss mice. Alstonine's cytotoxic effect was selective only to the tumor cells, and it inhibited DNA synthesis in vitro by forming an alkaloid-DNA complex. 30 However, alstonine was only partially effective in solid tumors because it could only moderately alter the growth kinetics. 31 Multiple reports also suggest that the triterpenoid lupeol present in A scholaris and other plants like olive and mango possesses antiproliferative activities in various neoplastic cells of different histological origins, such as in the human melanoma 451Lu cells, 32 WM35 cells, 32 and B162F2 cells 33 ; human pancreatic adenocarcinoma cells, AsPC-1 34 ; human epidermoid carcinoma A431 cells 35 ; hepatocellular carcinoma SMMC7721 cells 36 ; and prostate carcinoma cells LNCaP, 37, 38 CWR22Rγ1, 37 and PC-3. 39 At equivalent concentrations, lupeol was not cytotoxic to the nonneoplastic normal cells, suggesting that it possess selective antineoplastic effects. 32, 34, 37 Feeding of lupeol significantly reduced the growth of 451Lu and CWR22Rnu1 tumor in athymic nude mice by modulating the expression of proliferation markers, apoptotic markers, and cell cycle regulatory molecules in tumor xenografts. 32, 34 Lupeol caused G1-S phase cell cycle arrest and decreased expression of cyclin D1, cyclin D2, and cdk2, with concomitant increase in the expression of p21 protein in PC-3 cells. 39 It also caused reduction in the expression of Ras oncoprotein and modulated the expression of signaling molecules involved in PKCα/ODC, PI3K/Akt, MAPKs, and NFκB signaling pathway in AsPC-1. 34 It decreased the expression of death receptor 3 (DR3) and elevated the expression of FADD mRNA in SMMC7721 cells. 36 Lupeol modulates the expression of ERBB2, tissue inhibitor of metalloproteinases-3, cyclin D1, and matrix metalloproteinase (MMP)-2 genes, which are associated with proliferation and survival in LNCaP cells. 38 Lupeol inhibited the expression of cyclin B, cdc25C, and plk1 but induced the expression of 14-3-3sigma genes in PC-3 cells. 39 Reports suggest that lupeol induces apoptosis by downregulating Bcl2, upregulating Bax, activating caspase-3, and inducing poly(ADP)ribose polymerase cleavage, and activating caspase-3, -9, and apaf1 genes in CWR22Rnu1 and PC-3 neoplastic cells. 32, 39 Lupeol treatment increases reactive oxygen species, causes loss of mitochondrial membrane potential and induces DNA fragmentation in PC-3 cells. 39 It also attenuated stress fiber assembly, decreased phosphocofilin, and inhibited the haptotaxis of B16 2F2 melanoma cells to fibronectin. 33
Chemomodulatory and Radiomodulatory Effects
The use of ionizing radiation and chemotherapeutic drugs although beneficial, causes untoward effects because of normal tissue toxicity. 40 In such situations, an agent that can provide a therapeutic differential between the cancer and normal cell will be highly beneficial because selective antitumoral activity can be ensured and normal cells will not be affected. 40 Therapeutic differential may be achieved with chemical compounds that selectively enhance the chemotherapeutic drug's or radiation's antineoplastic effects (chemosensitizers and radiation sensitizers) or by selectively protecting the normal cells from the deleterious effects of radiation and chemotherapeutic agents (chemoprotectors and radioprotectors). 16, 40, 41 Studies carried out in the recent past have shown that the ethanolic extract of A scholaris possesses radiosensitizing, radioprotective, and chemosensitization effects. Furthermore, lupeol and its ester, lupeol linoleate, have also been reported to protect rats against cyclophosphamide-induced cardiotoxicity. In the following sections, these observations and the mechanisms responsible for these effects are discussed.
Chemosensitization Effects
Cyclophosphamide, although a useful anticancer drug, induces debilitating toxic effects on patients. 42 Studies suggest that combining plant derivatives with chemotherapeutic agents may increase antineoplastic efficacy and reduce the toxic effects. Accordingly, studies were planned in which a combination of cyclophosphamide and A scholaris was tested in Ehrlich ascites carcinoma-bearing mice. 43 The tumor-bearing animals were injected with various doses of extract and 25 mg/kg of cyclophosphamide (1/10th of the LD 50 dose). The combination of 120 mg/kg of extract with 25 mg/kg of cyclophosphamide was most effective because it resulted in the highest level of tumor regression and enhanced the survival time of the tumor-bearing animals. Similarly, when 120 mg/kg of extract was combined with different doses of cyclophosphamide, a dose-dependent increase in the anticancer activity was observed up to 25 mg/ kg of cyclophosphamide, beyond which toxic manifestations were observed. Extract administration before treatment with cyclophosphamide resulted in a drastic decline in the levels of glutathione and increased lipid peroxidation considerably when compared with the drug and radiation-alone groups. 43 Echitamine in combination with vitamin A enhanced the cytotoxic effects on Ehrlich ascites carcinoma in vitro by a free-radical-dependent mechanism and was similar to that of adriyamycin, mitomycin-C, and bleomycin. 26 All these studies suggest that echitamine is also an effective chemomodulatory agent and with further studies could possibly be of use as an adjuvant in cancer treatment.
Chemoprotective Effects
Feeding of lupeol and its ester, lupeol linoleate (50 mg/kg body weight for 10 days orally), prevented cyclophosphamideinduced oxidative stress and rectified the changes in serum lipoproteins, lipid fractions, and the activity of lipid metabolizing enzymes in the cardiac tissues of rats. 44, 45 Lupeol decreased the cyclophosphamide-induced increase in the activities of lysosomal hydrolases in serum and heart, and increased the levels of cellular thiols. 46 Lupeol increased the activities of TCA cycle enzymes (succinate dehydrogenase, malate dehydrogenase, isocitrate dehydrogenase) and mitochondrial complexes of the electron transport chain in cardiac tissue. 47 The altered cardiac electrolytes were normalized, and the activities of ATPases were increased. The levels of urea, uric acid, and creatinine were also normalized, suggestive of its protective effects. 48 The hisopathological studies showed a decrease in the levels of intermuscular hemorrhage confirming the cardioprotective effects. 45 Electron microscopic analysis of the heart tissues showed that the degree of damage to the myofibers, characterized by the swelling and loss of myofilaments, mitochondrial swelling, and damaged cristae were also decreased. These studies demonstrated that supplementation with lupeol and its ester could preserve lysosomal integrity and improve thiol levels. 46, 47 Together all these results indicate that supplementation with lupeol and its ester protected rats against cyclophosphamide-induced cardiotoxicity.
Radiation Sensitizers
The radiosensitizing effect of the alkaloid fraction of the extract was evaluated in neoplastic cell lines of different histological origins HeLa, HepG2, HL60, MCF-7, and KB. Pretreatment with 5 µg/mL of the extract before exposure to γ-radiation enhanced the radiation cytotoxicty. The effect was more pronounced in the HeLa and KB cells, followed by HL60, MCF7, and HepG2 cells. 49 The in vitro observations also extended to the in vivo studies, where it was observed that the intraperitoneal treatment of tumor-bearing animals with 240 mg/kg body weight of the extract resulted in a higher level of tumor remission when compared with the concurrentradiation-alone and drug-alone cohorts. 49 
Radioprotection
Recently, Gupta et al 50 have observed that oral administration (25, 50, 75, 100, 150 , and 200 mg/kg body weight) of the ethanolic extract of the bark for 5 consecutive days before exposure to a lethal dose of γ-radiation (7.5 Gy) prevented radiation-induced sickness and mortality. The optimal effect was seen at 100 mg/kg body weight, which resulted in nearly 90% survivals at the end of day 30 postirradiation. The extract prevented radiation-induced hematopoietic damage, and high erythrocyte number, hematocrit, and hemoglobin levels were observed. Considerable reduction in the levels of lipid peroxidation along with a concomitant increase in glutathione in both serum and liver were also observed. 50 All these results suggest that protection of the hemopoetic system, restoration of glutathione, and decreasing lipid peroxidation by the sapthaparna extract may have been responsible for the observed radioprotective effects.
Chemopreventive Effects
Chemoprevention, a science that has emerged during the last 3 decades, presents an alternative approach to reducing mortality from cancer. It aims to block, reverse, or delay carcinogenesis before the development of invasive disease by targeting key molecular derangements using pharmacological or nutritional agents at nontoxic concentrations. 51 The chemopreventive effects of various doses of hydroalcoholic extract of A scholaris were studied on benzo(a)pyrene [b(a)p]-induced forestomach carcinogenesis in mice. Treatment of mice with 1, 2, and 4 mg/mL extract (0.1%, 0.2%, and 0.4%) in drinking water before, during, and after the treatment with b(a)p, resulted in chemopreventive activity. The highest effect was observed for the 4 mg/mL extract, where the tumor incidence and multiplicity were reduced. However, the pre-only or post-only treatment of mice with 4 mg/mL extract was not as effective as the pre-post treatment. The micronucleus study, which indicates DNA damage, also showed that feeding the extract decreased the mutagenic effect of b(a)p and that this property could have contributed at least in part to the observed chemopreventive effects. 52 Recently, Jahan et al 53 have also reported that sapthaparna prevents 7,2-dimethylbenz(a)anthracene (DMBA)-induced and croton oil-promoted skin carcinogenesis in mice. Feeding of the hydroalcoholic extract of sapthaparna at 100 mg/kg body weight for 14 consecutive days-7 days before and 7 days after the DMBA application-decreased the tumor incidence, tumor yield, tumor burden, and cumulative number of papillomas when compared with the carcinogen-treated control (without sapthaparna treatment). Sapthaparna increased the levels of reduced glutathione, superoxide dismutase, and catalase, and concomitantly decreased lipid peroxidation when compared with the carcinogen-treated cohorts. 53 Furthermore, Salem et al 54 have also shown that administration of lupeol (1-2 mg/mouse) 30 minutes prior to 12-O-tetradecanoylphorbol 13-acetate(TPA) application on mouse skin inhibited the TPA-mediated increase in skin edema and hyperplasia, epidermal ornithine decarboxylase activity, and protein expression of ODC, cyclooxygenase-2, and nitric oxide synthase. It also inhibited the activation of PI3K, phosphorylation of Akt at Thr (308), activation of NF-κΒ and IKKα, and degradation and phosphorylation of IKKα. 54 Topical application of 2 mg lupeol significantly reduced DMBA-induced TPA-promoted incidence of tumor and tumor body burden and caused a delay in the latency period for tumor appearance. At the termination of the experiment (28 weeks), all animals in the TPA-treated group exhibited 7 to 8 tumors/mouse, whereas in the lupeol pretreated groups, nearly half of the animals had 1 to 3 tumors/mouse, suggesting its effectiveness as a chemopreventive agent. 54 Lupeol prevented DMBA-induced DNA damage 55 and modulated DMBA-induced alterations on cell proliferation in the mouse skin, 56 which cumulatively might have contributed toward inhibition of DMBA-mediated neoplasia. Lupeol induced G2/M-phase arrest through inhibition of the cyclin-B-regulated signaling pathway involving p53, p21/WAF1, cdc25C, cdc2, and cyclin-B gene expression and induced apoptosis by upregulation of bax and caspase-3 genes and downregulation of antiapoptotic bcl-2 and survivin genes. 56 The ethanolic extract of A scholaris contains the lupane triterpenoid lupeol, the ursane triterpenoid α-amyrin and esters of these compounds. Studies by Rajic et al 57 have shown that α-amyrin is a competitive inhibitor of bovine trypsin and chymotrypsin; lupeol palmitate and α-amyrin linoleate are noncompetitive inhibitors of trypsin; α-amyrin linoleate is a noncompetitive inhibitor of chymotrypsin; lupeol is a competitive inhibitor of both trypsin and chymotrypsin; and α-amyrin palmitate is a potent noncompetitive inhibitor of chymotrypsin. These hydrophobic triterpenoids possess antiinflammatory effects and also inhibit serine proteases and protein kinase A, which are important steps in inhibiting cell proliferation, tumor promotion, and progression. 57
Mechanisms Responsible for the Radioprotective and Chemopreventive Effects Free-Radical Scavenging and Antioxidant Effects
Studies have shown that free radicals, including reactive oxygen and nitrogen species, are linked with the pathological state of numerous diseases, including cancer. These electrophilic agents oxidize and subsequently damage cellular macromolecules and, especially when the DNA is damaged, may cause mutations that may lead to cancer. 58 The ethanolic extract of A scholaris leaves possesses freeradical scavenging, metal ion chelating, superoxide anion scavenging, hydrogen peroxide scavenging, and ferric thiocyanate reducing activities in vitro. 59 The extract prevented oxidant-induced lipid peroxidation and radical chain reactions with results comparable with that of BHA, BHT, L-ascorbic acid, and β-tocopherol. 3 Studies have also shown that the ethanolic extract of the bark possesses considerable nitrogen oxide scavenging effects. 60 
Anti-inflammatory Activities
Inflammation is a pathophysiological phenomenon known to be involved in numerous diseases, and mounting evidence suggests that the risk of developing cancer is dramatically increased for patients with chronic inflammatory diseases. Inhibitors that block the generation of reactive oxygen, nitrogen species, and inflammatory pathways may inhibit carcinogenic processes, and in the recent past, studies have been done on developing a nontoxic anti-inflammatory agent, preferably with antioxidant and antimutagenic effects to ensure chemoprevention. 61 Studies by Arulmozhi et al 59 have shown that that the ethanolic extract of leaves at 200 and 400 mg/kg significantly inhibited chemically induced (carrageenan-induced) inflammation in the rat paw edema study model, suggesting that the anti-inflammatory mechanism also contributed to the beneficial effects and prevention of cancer. 59 The lupane triterpenoid lupeol, the ursane triterpenoid α-amyrin, and esters of these compounds are observed to possess anti-inflammatory effects and inhibitors of protein kinase A. 57 Recently, Shang et al 61 have observed that the ethanolic extract, fractions, and main alkaloids of A scholaris leaf inhibited xylene-induced ear edema. Detailed studies showed that the alkaloids increased the superoxide dismutase activity and concomitantly decreased the levels of nitric oxide, prostaglandin E-2, and lipid peroxidation significantly in the air pouch mice model. Furthermore, some alkaloids inhibited cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase in the in vitro anti-inflammatory assay; these results are in congruence with the animal studies. The compounds 16-formyl-5α-methoxystrictamine, picralinal, and tubotaiwine are observed to be dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase and could be of immense use in controlling and preventing inflammatory response. 61 
Antimutagenic Activity
Carcinogenesis involves a complex series of events, and induction of DNA damage and mutations are the earliest steps. Studies with mice have shown that A scholaris possesses antimutagenic effects against methylmethanesulfonate, mitomycin C, and dimethylnitrosamine. Administration of A scholaris prevented DNA damage in mice bone marrow cells by these clastogens, as evaluated by the micronucleus assay. 62, 63 Treatment of mice with extract before, during, and after the carcinogen b(a)p reduced forestomach carcinoma in mice and the frequency of micronuclei in splenocytes. Administration of the extract not only reduced the frequency of splenocytes bearing 1 micronuclei but also cells bearing multiple micronuclei, indicating the efficacy of the extract in inhibiting mutagenic changes induced by b(a)p and its effect on carcinogenesis. 52 The pre-alone or post-alone treatment of mice with extract reduced the frequency of b(a)p-induced micronuclei in the splenocytes of treated animals. However, the effect was not as good as the pre-post regimen. 52 Topical application of lupeol reduced DMBA-induced DNA strand breaks in mouse skin at all sampling times (25, 48, 72 , and 96 hours post-DMBA application). Both pretreatment and posttreatment of lupeol possessed significant preventive effects and were dose and time dependent. At the dose of 200 mg/mouse, lupeol pretreatment resulted in nearly 56.05% prevention, whereas with posttreatment at the same dose, 43.26% reduction in the DMBA-induced DNA damage was observed at the 96-hour time interval. 55 
Immunomodulatory Activity
Immune activation is a protective approach against emerging infectious diseases and certain cancers. Immunostimulants enhance the overall immunity of the host and present a nonspecific immune response against the microbial pathogens. Certain phytochemicals are known to increase the humoral and cellular immune responses by either enhancing cytokine secretion or by directly stimulating B-or T-lymphocytes. 64 Iwo et al 65 showed that the aqueous extract of A scholaris bark was better than that of the ethanolic extract, inducing an immunostimulating effect in the BALB/c mouse. The aqueous extract increased the lytic activity of peritoneal exudate cells against Escherichia coli because of the cellular immune response. The aqueous extract had no effect on primary antibody level and inhibited the delayed type of hypersensitivity reaction. 65 The investigators observed that the aqueous extract of A scholaris was able to stimulate nonspecific immune response, increase the phagocytic activity, restore the reduction of phagocytic action induced by the immunotoxin prednisole, and protect the body from opportunistic infections. 65
Conclusion and Future Directions
Preclinical studies in the recent past suggest the usefulness of A scholaris in the treatment and prevention of cancer, and these observations confirm the ethnobotanical observations. Although most research has been with experimental animals and clinical applicability to humans has been validated, studies with tumor-bearing animals with varied metastatic potential and selective antineoplastic, chemomodulatory and radiomodulatory, and toxicity studies need to be performed. Mechanistic and toxicity studies with the individual phytochemicals like echitamine, alstonine, pleiocarpamine, O-methylmacralstonine, macralstonine, and lupeol along with the whole extract are also required.
Studies have shown that the bark extract was toxic to mice and rats at high concentrations and that the toxicity depended on the season of plant collection, the route of extract administration, the animal species, and strain. The extract prepared in summer was the most toxic followed by those prepared during the winter and monsoon; the Swiss albino mice were the most sensitive, followed by the DBA and C 57 BL. The crossbred mice were more resistant than pure inbred strains, and rats were more sensitive than mice. The extract, when orally administered, was nontoxic up to a dose of 2000 mg/kg body weight, whereas a dose of 1100 mg/kg by the intraperitoneal route was toxic to mice. 66 Studies have shown that the extract of A scholaris possesses systemic toxicity when administered at 120 and 240 mg/kg body weight (1/10th and 1/5th of the LD 50 dose) for 30 consecutive days by the intraperitoneal route. 66 Furthermore, the extract at 360 or 480 mg/kg (which corresponds to 3/10th and 4/10th of the LD 50 dose) when administered through the intraperitoneal route was teratogenic to mice. 66, 67 However, the concentrations used in these studies are very high, and the stated route is rarely used by patients.
Detailed toxicity studies are warranted with a range of doses by adopting the oral route because it is the most preferred route of administration in humans. It is quite possible that the extract may not be toxic when administered through the oral route, and the observation that the extract is nontoxic even at 2000 mg/kg body weight justifies this conviction. 66 Because of its advocacy in traditional medicines, wide distribution, and ease in judicious harvesting, A scholaris may have the potential to develop as an effective anticancer, chemopreventive agent and an adjuvant to cancer treatment but only when the gaps in the current knowledge are bridged. When concerted efforts are directed at understanding the existing lacunae, a realistic appraisal of A scholaris as a novel agent in the treatment and prevention of cancer would be realized. Till then caution needs to be adopted while consuming high concentrations of the bark decoction, especially by pregnant women.
